Argon to pay $362.5M for Angiotech's interventional biz

Argon Medical Devices has agreed to pay $362.5 million to acquire Angiotech Pharmaceuticals' interventional products unit. The cash deal, set to be finalized by the end of next month, covers Angiotech's drainage catheters, biopsy systems and related products.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY